Identification of a novelHLA-A*33:03:11allele by polymerase chain reaction sequence-based typing in a Chinese cord blood donor

2013 ◽  
Vol 82 (1) ◽  
pp. 59-60 ◽  
Author(s):  
W. Zhang ◽  
S.-D. Tao ◽  
F.-M. Zhu ◽  
J. He ◽  
H.-J. Lv

HLA ◽  
2017 ◽  
Vol 90 (2) ◽  
pp. 118-120 ◽  
Author(s):  
N.-Y. Chen ◽  
W. Wang ◽  
L.-N. Dong ◽  
J. He ◽  
F.-M. Zhu


HLA ◽  
2016 ◽  
Vol 87 (5) ◽  
pp. 384-385 ◽  
Author(s):  
L.-N. Dong ◽  
N.-Y. Chen ◽  
W. Zhang ◽  
J. He ◽  
F.-M. Zhu


HLA ◽  
2017 ◽  
Vol 89 (4) ◽  
pp. 241-242 ◽  
Author(s):  
J. He ◽  
N.-Y. Chen ◽  
Z.-D. Han ◽  
W. Zhang ◽  
F.-M. Zhu


HLA ◽  
2016 ◽  
Vol 89 (1) ◽  
pp. 64-65 ◽  
Author(s):  
L.-N. Dong ◽  
Z.-D. Han ◽  
W. Zhang ◽  
J. He ◽  
F.-M. Zhu




2018 ◽  
Vol 41 (5) ◽  
pp. 284-288
Author(s):  
Marco Guarene ◽  
Carla Badulli ◽  
Anna L Cremaschi ◽  
Ilaria Sbarsi ◽  
Rosalia Cacciatore ◽  
...  

Introduction: Allele-level donor–recipient match at HLA-A, HLA-B, HLA-C and HLA-DRB1 loci impacts the outcome after cord blood transplantation for hematologic malignancies and modifies the strategy of donor selection. High definition of both class I and II HLA loci at time of listing is a way to improve the attractiveness of cord blood bank inventories, reducing the time for donor search and procurement and simplifying donor choice, in particular, for patients of non-European heritage. Methods: In 2014, Luminex® xMAP® technology was introduced in our laboratory practice and was applied to cord blood units typing. In this study, we evaluated the impact of this strategy in comparison with the platform in use until 2013, relying on LiPA reverse polymerase chain reaction–sequence-specific oligonucleotide (revPCR-SSO) plus polymerase chain reaction–sequence-specific primer (PCR-SSP). Results: In 2014, the time for testing was shorter (141 vs 181 days on average), the number of test repetitions was lower (in particular for HLA-A locus, p = 0.026), and the cost reduced (240.7 vs 395.6 euros per unit on average) compared to 2013, demonstrating that Luminex xMAP technology is superior to the previous approach. Conclusion: Luminex xMAP platform has useful application in cord blood banking programs, to achieve high-definition HLA typing of cord blood units at the time of banking in a quick, accurate, and cost-effective manner.



2011 ◽  
Vol 78 (3) ◽  
pp. 226-227 ◽  
Author(s):  
F.-M. Zhu ◽  
W. Wang ◽  
W. Zhang ◽  
H.-J. Lv ◽  
L.-X. Yan


Author(s):  
E B Duly ◽  
A J Ward ◽  
C W Kirk ◽  
N C Nevin ◽  
T R Trinick ◽  
...  

Apolipoprotein E genotypes were measured in 83 patients with familial hypercholesterolaemia (FH) and in 175 blood donor controls. Following DNA extraction from peripheral blood, each sample was genotyped for the Apo E polymorphism by polymerase chain reaction. No significant differences were found in the levels of the ε2 and ε3 alleles between the two groups, while the ε4 allele was approximately twice as prevalent in the FH patients as in controls ( P = 0·006, df = 1). Of the FH patients, 8·4% were homozygous for the ε4 allele while this genotype was rare in controls ( P = 0·009, df = 1). These results suggest that the ε4 allele is over represented in the FH population and may contribute to increased cholesterol levels and consequent vascular disease.





2013 ◽  
Vol 82 (1) ◽  
pp. 65-66 ◽  
Author(s):  
S. -D. Tao ◽  
W. Zhang ◽  
F. -M. Zhu ◽  
J. He ◽  
H.-J. Lv


Sign in / Sign up

Export Citation Format

Share Document